Evaluation of race and ethnicity disparities in outcome studies of CYP2C19 genotype-guided antiplatelet therapy

Dual antiplatelet therapy with a P2Y(12) inhibitor (clopidogrel, prasugrel, or ticagrelor) and aspirin remains the standard of care for all patients undergoing percutaneous coronary intervention (PCI). It is well-established that patients carrying CYP2C19 no function alleles have impaired capacity t...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Anh B., Cavallari, Larisa H., Rossi, Joseph S., Stouffer, George A., Lee, Craig R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445150/
https://www.ncbi.nlm.nih.gov/pubmed/36082121
http://dx.doi.org/10.3389/fcvm.2022.991646

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445150/
https://www.ncbi.nlm.nih.gov/pubmed/36082121
http://dx.doi.org/10.3389/fcvm.2022.991646

Ejemplares similares